Galatea Surgical

As a wholly-owned subsidiary of Tepha, Inc., Galatea Surgical, Inc. was acquired in 2012 and is dedicated to enhancing and extending the longevity of cosmetic procedures through the use and application of next-generation biomaterials, P4HB™ (poly-4-hydroxybutyrate) biopolymers. By providing patients and surgeons with monofilament bioresorbable devices that enable the patient's own body to generate new tissue, stronger repairs can be achieved, aiming for longer-lasting and more durable results. With its proprietary monofilament bioresorbable scaffolds, Galatea Surgical is "where science meets art."